Therapy and clinical trials: Aggressive statin therapy versus combined and emerging approaches

QR Code

Therapy and clinical trials: Aggressive statin therapy versus combined and emerging approaches

Bibliographic Details
Main Authors:	Catapano, A., Norata, Giuseppe, Pirillo, A.
Format:	Journal Article
Published:	Lippincott Williams & Wilkins 2011
Online Access:	http://hdl.handle.net/20.500.11937/55809

Similar Items

Statins and skeletal muscles toxicity: From clinical trials to everyday practice
by: Norata, Giuseppe, et al.
Published: (2014)

Strategies for the use of nonstatin therapies
by: Pirillo, A., et al.
Published: (2017)

Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy?
by: Catapano, A., et al.
Published: (2017)

Statins and periodontal inflammation: A pleiotropic effect of statins or a pleiotropic effect of LDL-cholesterol lowering?
by: Norata, Giuseppe, et al.
Published: (2014)

PCSK9 inhibition in statin-intolerant HeFH patients: What's new?
by: Casula, M., et al.
Published: (2017)

Vascular inflammation and low-density lipoproteins: Is cholesterol the link? A lesson from the clinical trials
by: Catapano, A., et al.
Published: (2017)

Treating high density lipoprotein cholesterol (HDL-C): Quantity versus quality
by: Pirillo, A., et al.
Published: (2013)

Emerging role of high density lipoproteins as a player in the immune system
by: Norata, Giuseppe, et al.
Published: (2012)

Naphthoquine: An Emerging Candidate for Artemisinin Combination Therapy
by: Moore, Brioni, et al.
Published: (2016)

The effectiveness of non-clozapine antipsychotics combined with electroconvulsive therapy versus clozapine combined with electroconvulsive therapy for treatment-resistant schizophrenia
by: Pichai Ittasakul,, et al.
Published: (2021)

HDLs, immunity, and atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2011)

High-density lipoprotein subfractions - What the clinicians need to know
by: Pirillo, A., et al.
Published: (2013)

Postprandial lipemia as a cardiometabolic risk factor
by: Pirillo, A., et al.
Published: (2014)

Niemann-pick C1-like 1 (NPC1L1) inhibition and cardiovascular diseases
by: Pirillo, A., et al.
Published: (2016)

LOX-1, OxLDL, and atherosclerosis
by: Pirillo, A., et al.
Published: (2013)

HDL in infectious diseases and sepsis
by: Pirillo, A., et al.
Published: (2015)

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: Patient selection and perspectives
by: Catapano, A., et al.
Published: (2017)

Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson’s disease: a large pragmatic randomised controlled trial (PD REHAB)
by: Clarke, Carl E., et al.
Published: (2016)

Physiotherapy and occupational therapy vs no therapy in mild to moderate Parkinson disease: a randomized clinical trial
by: Clarke, Carl E., et al.
Published: (2016)

Apolipoprotein C-III: From Pathophysiology to Pharmacology
by: Norata, Giuseppe, et al.
Published: (2015)

Simulated versus traditional occupational therapy placements: A randomised controlled trial
by: Imms, C., et al.
Published: (2018)

High density lipoproteins and atherosclerosis: Emerging aspects
by: Sala, F., et al.
Published: (2012)

Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism.
by: Caparrós-Martín, J., et al.
Published: (2017)

A Trial of Combination Antimalarial Therapies in Children from Papua New Guinea
by: Karunajeewa, H., et al.
Published: (2008)

PCSK9 inhibition for the treatment of hypercholesterolemia: Promises and emerging challenges
by: Norata, Giuseppe, et al.
Published: (2014)

Stem cell therapies for myocardial infarction in clinical trials: bioengineering and biomaterial aspects
by: Higuchi, Akon, et al.
Published: (2017)

Current and emerging therapies for corneal infection: a clinical and laboratory study
by: Ting, Darren Shu Jeng
Published: (2022)

PD REHAB: a large pragmatic randomised controlled trial of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease
by: Clarke, C.E., et al.
Published: (2014)

The Patterns Of Prescribing, Health Beliefs And Adherence To Statin Therapy Among Patients With High Cardiovascular Disease Risk And Health Care Providers’ Knowledge, Attitude, Barriers And Practice Regarding Cardiovascular Risk Assessment And Statin Therapy In Yemen
by: Al-Ashwal, Fahmi Yahya Ahmed
Published: (2022)

The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis
by: Pirillo, A., et al.
Published: (2018)

HDL: To treat or not to treat?
by: Pirillo, A., et al.
Published: (2014)

HDL in innate and adaptive immunity
by: Catapano, A., et al.
Published: (2014)

A randomised controlled trial of group cognitive behavioural therapy for clinical perfectionism
by: Handley, Alicia Katherine
Published: (2014)

Cost-Effectiveness Of Warfarin Medication Therapy Adherence Clinic Versus Usual Medical Clinic At Kuala Lumpur Hospital
by: Thanimalai, Subramaniam
Published: (2016)

Statin therapy prescribing for patients with type 2 diabetes mellitus: a review of current evidence and challenges
by: Elnaem, Mohamed Hassan Abdelaziz, et al.
Published: (2017)

Discontinuation and restarting in patients on statin therapy: a cohort study using a primary care database
by: Vinogradova, Yana, et al.
Published: (2016)

Frequency of Intensive Statin Therapy in Patients With Acute Coronary Syndrome Admitted to a Tertiary Care Center
by: Shiu, J., et al.
Published: (2012)

Biology of proprotein convertase subtilisin kexin 9: Beyond low-density lipoprotein cholesterol lowering
by: Norata, Giuseppe, et al.
Published: (2016)

Long pentraxin 3: Experimental and clinical relevance in cardiovascular diseases
by: Bonacina, F., et al.
Published: (2013)

Parenting intervention combined with acceptance and commitment therapy: A trial with families of children with cerebral palsy
by: Whittingham, K., et al.
Published: (2016)